[go: up one dir, main page]

Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

FDA Approves Lilly's Ebglyss (lebrikizumab) for Atopic Dermatitis

Ebglyss provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled...

FDA Approves Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy

September 12, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration...

Ovarian Cancer in the Family? Know Your Risks

Nearly a quarter of all ovarian cancers are fueled by family genetics, so what should you do if your mom or sister are diagnosed?According to one expert,...

Why Beans Are a Natural Superfood

Beans may sometimes give you gas, but one expert says that shouldn't stop you from finding ways to include them in your diet.Why? Because they are packed...

Vico Therapeutics Announces Positive Interim Phase 1/2a Clinical Data of VO659 in Treatment of Huntington's Disease

LEIDEN, Netherlands, Sept. 13, 2024. Vico Therapeutics B.V., a clinical-stage genetic medicines company developing therapies for severe neurological diseases,...

Limited Progress on QoL Goals Reported for Persons With HIV Aged 50 Years and Older

For persons diagnosed with HIV (PWH) aged 50 years and older, progress on quality of life (QoL) goals is limited, according to a study published online...

Boar's Head Will Close Virginia Plant Linked to Listeria-Tainted Deli Meats

Boar's Head announced Friday that its Jarratt, Va. deli meat manufacturing plant, found to be the source of a deadly outbreak of listeria infections,...

Ozempic or Saxenda for Weight Loss: Which Works Best?

Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar...

Predictive Models for HTN Screening Developed Using Speech Recordings

Predictive models for hypertension screening have been developed using speech recordings, with accuracies up to 84 percent for women and 77 percent for...

Sulthiame Beneficial for Symptoms of Obstructive Sleep Apnea

Sulthiame (STM) is beneficial for improving symptoms of obstructive sleep apnea (OSA), according to a study presented at the European Respiratory...

Time-Restricted Eating Helps to Improve Diabetes Outcomes

Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study presented at the annual meeting of the European...

Neurocrine Biosciences Provides Update on ERUDITE Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia

SAN DIEGO, Sept. 12, 2024. Neurocrine Biosciences, Inc. today announced that its ERUDITE Phase 2 clinical study of investigational compound luvadaxistat...

Drug Safety Communication: FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause

The FDA is warning that Veozah (fezolinetant), a medicine used to treat hot flashes due to menopause, can cause rare but serious liver injury.  If...

Ingredient in Hair Dye Led to Woman's Vision Loss

An ingredient in the hair dye a French woman used caused her to develop a vision-robbing retinopathy, researchers report. When she switched to a dye without...

Read more news...

Recently Added

Recently added consumer and prescribing information: Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive, Ohtuvayre, Sofdra

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Ebglyss Ebglyss (lebrikizumab-lbkz) is a targeted IL-13 inhibitor used for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults...
  • Pavblu Pavblu (aflibercept-ayyh) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
  • Lazcluze Lazcluze (lazertinib) is a kinase inhibitor used in combination with amivantamab for the treatment of certain patients with epidermal...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development